NeuroNEXT

Dr. Tara Carlisle is originally from Grand Junction, CO. She worked with researcher and educator William B. Wood, PhD, in his C. elegans developmental biology lab as a pre-medical student at the University of Colorado-Boulder. She joined the Medical Scientist Training Program at the University of Colorado Anschutz Medical Campus and completed a PhD in Neuroscience , where she studied activity-dependent processes in the developing spinal cord of Danio rerio (zebrafish) with Angeles B. Ribera, PhD. She completed an Internal Medicine internship with CU Anschutz, Neurology Residency with Partners (Massachusetts General/Brigham & Women’s/Harvard) Neurology in Boston, MA, and a Behavioral Neurology & Neuropsychiatry Fellowship at CU Anschutz. Dr. Carlisle has particular interests in predicting cognitive decline and in cognitive reserve. She has ongoing projects on developing a clinical tool focusing on potentially modifiable and/or reversible risk factors to predict those at high risk of developing cognitive decline in Parkinson’s disease, sex differences in Alzheimer’s disease risk and contributions of sex hormone exposure to cognitive reserve, and acting as a dementia expert on a team developing a roadmap as a tool for making decisions about care along the cognitive spectrum. For her NeuroNEXT fellowship, she is investigating the risks and gathering preliminary data on the benefits of anti-amyloid therapy for individuals with atypical Alzheimer’s disease.